[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2018

March 2018 | 529 pages | ID: TE6CCE57CD2EN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2018

SUMMARY

GlobalData's Medical Devices sector report, “Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2018' provides an overview of Transdermal Drug Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Transdermal Drug Delivery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transdermal Drug Delivery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transdermal Drug Delivery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Transdermal Drug Delivery Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Transdermal Drug Delivery - Pipeline Products by Stage of Development
3.2 Transdermal Drug Delivery - Pipeline Products by Segment
3.3 Transdermal Drug Delivery - Pipeline Products by Territory
3.4 Transdermal Drug Delivery - Pipeline Products by Regulatory Path
3.5 Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
3.6 Transdermal Drug Delivery - Ongoing Clinical Trials

4 TRANSDERMAL DRUG DELIVERY - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development
4.2 Transdermal Drug Delivery - Pipeline Products by Stage of Development

5 TRANSDERMAL DRUG DELIVERY COMPANIES AND PRODUCT OVERVIEW

5.1 4P Therapeutics LLC Company Overview
5.2 Actuated Medical Inc Company Overview
5.3 Aequus Pharmaceuticals Inc Company Overview
5.4 Agile Therapeutics Inc Company Overview
5.5 Allergan Plc Company Overview
5.6 Alliqua BioMedical Inc Company Overview
5.7 Altea Therapeutics Corporation (Inactive) Company Overview
5.8 AMW GmbH Company Overview
5.9 AngioSoma Inc Company Overview
5.10 Apogee Technology Inc Company Overview
5.11 Apricus Biosciences Inc Company Overview
5.12 Asahi Kasei Pharma Corp Company Overview
5.13 AstraZeneca Plc Company Overview
5.14 Avro Life Sciences Company Overview
5.15 Burke Pharmaceuticals LLC Company Overview
5.16 CB Scientific Inc. Company Overview
5.17 Cerimon Pharmaceuticals, Inc. (Inactive) Company Overview
5.18 Chrono Therapeutics Inc Company Overview
5.19 Corium International Inc Company Overview
5.20 DBV Technologies SA Company Overview
5.21 DD Therapeutics LLC Company Overview
5.22 Dermisonics Inc (Inactive) Company Overview
5.23 Dharma Therapeutics, Inc. (Inactive) Company Overview
5.24 Drexel University Company Overview
5.25 DURECT Corp Company Overview
5.26 Echo Therapeutics Inc Company Overview
5.27 Emplicure AB Company Overview
5.28 Endo International Plc Company Overview
5.29 Extend Biosciences Inc Company Overview
5.30 EyeGate Pharmaceuticals Inc Company Overview
5.31 Fe3 Medical Inc Company Overview
5.32 Hisamitsu Pharmaceutical Co Inc Company Overview
5.33 ImmuPatch Company Overview
5.34 Indian Institute of Science Company Overview
5.35 Indian Institute of Technology Bombay Company Overview
5.36 InMed Pharmaceuticals Inc Company Overview
5.37 Institute of Materials Research & Engineering Company Overview
5.38 Intercell AG (Inactive) Company Overview
5.39 Interstitial NS Company Overview
5.40 Isis Biopolymer, Inc. Company Overview
5.41 Janisys Company Overview
5.42 KTH Royal Institute of Technology Company Overview
5.43 Kyowa Hakko Kirin Co Ltd Company Overview
5.44 Lohmann Therapie-Systeme AG Company Overview
5.45 Massachusetts Institute of Technology Company Overview
5.46 Mayne Pharma Group Ltd Company Overview
5.47 Medherant Ltd Company Overview
5.48 MEDRx Co Ltd Company Overview
5.49 MedRx, Inc. Company Overview
5.50 Microdermics Inc Company Overview
5.51 Micron Biomedical Inc Company Overview
5.52 Micropoint Technologies Pte Ltd Company Overview
5.53 Nemaura Pharma Ltd Company Overview
5.54 NeuroDerm Ltd Company Overview
5.55 Nitto Denko Corp Company Overview
5.56 North Carolina State University Company Overview
5.57 Noven Pharmaceuticals Inc Company Overview
5.58 NutriBand Inc Company Overview
5.59 Nuvo Pharmaceuticals Inc Company Overview
5.60 Pain Therapeutics Inc Company Overview
5.61 Phosphagenics Ltd Company Overview
5.62 Prometheon Pharma LLC Company Overview
5.63 Purdue University Company Overview
5.64 Radius Health Inc Company Overview
5.65 Scilex Ltd Company Overview
5.66 Skinject Inc Company Overview
5.67 Sparsha Pharma International Pvt Ltd Company Overview
5.68 Sparsha Pharma USA Inc Company Overview
5.69 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.70 Stanford University Company Overview
5.71 Sumitomo Dainippon Pharma Co Ltd Company Overview
5.72 Syntropharma Ltd Company Overview
5.73 Taho Pharmaceuticals Ltd Company Overview
5.74 Teikoku Pharma USA Inc Company Overview
5.75 tesa Labtec GmbH Company Overview
5.76 Teva Pharmaceutical Industries Ltd Company Overview
5.77 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview
5.78 TheraJect Inc Company Overview
5.79 TheraSolve NV Company Overview
5.80 Theratech, Inc. Company Overview
5.81 Titan Pharmaceuticals Inc Company Overview
5.82 Transcu Group Limited (Inactive) Company Overview
5.83 Transdermal Delivery Solutions Corp Company Overview
5.84 Transdermal Specialties, Inc. Company Overview
5.85 TransPharma Medical Ltd (Inactive) Company Overview
5.86 Transport Pharmaceuticals Inc Company Overview
5.87 TSRL Inc Company Overview
5.88 Univec, Inc. (Inactive) Company Overview
5.89 University of Illinois at Chicago Company Overview
5.90 University of North Carolina at Chapel Hill Company Overview
5.91 University of North Carolina at Chapel Hill School of Medicine Company Overview
5.92 University of Toronto Company Overview
5.93 ViiV Healthcare UK Ltd Company Overview
5.94 Vyteris, Inc. (Inactive) Company Overview
5.95 Xel Pharmaceuticals Inc Company Overview
5.96 Zambon Italia Srl Company Overview
5.97 Z-Cube Srl Company Overview
5.98 Zosano Pharma Corp Company Overview
5.99 Zynerba Pharmaceuticals Inc Company Overview

6 TRANSDERMAL DRUG DELIVERY- RECENT DEVELOPMENTS

6.1 Mar 12, 2018: Radius Health to Present at ENDO 2018 Including Results of the ACTIVExtend BMD Responder Analysis for TYMLOS (abaloparatide) Injection
6.2 Mar 12, 2018: Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
6.3 Mar 12, 2018: Zosano Pharma Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Operational Update
6.4 Mar 09, 2018: Maura Dickler, M.D. To Become Vice President Of Late Phase Development At Lilly Oncology
6.5 Mar 07, 2018: Medherant expands team with appointment of David Davies as Head of Development
6.6 Mar 07, 2018: FDA Confirms Date to Providing Regulatory Guidance for Aequus’ Anti-Nausea Patch
6.7 Mar 05, 2018: 3M Announces New Leadership Appointments
6.8 Mar 02, 2018: Zosano Pharma Announces Issuance of New U.S. Patent Covering M207 as an Acute Treatment for Migraine
6.9 Mar 02, 2018: EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update
6.10 Mar 01, 2018: DURECT Announces Fourth Quarter and Full Year 2017 Financial Results and Update of Programs
6.11 Mar 01, 2018: Purdue Pharma L.P. Names Dr. Marcelo Bigal as Chief Medical Officer
6.12 Feb 28, 2018: Sorrento Therapeutics Subsidiary, Scilex, Receives US FDA Approval for Non-Opioid ZTlido (lidocaine topical system) 1.8% for PHN Pain
6.13 Feb 28, 2018: Revance Announces Fourth Quarter and Full Year 2017 Financial Results
6.14 Feb 28, 2018: Syneos Health Reports Fourth Quarter and Full Year 2017 Results
6.15 Feb 28, 2018: Agilent and Imperial College London Announce Collaboration Agreement
6.16 Feb 28, 2018: Otsuka Encourages Start-Ups to Spark the Next Generation of Innovation and Collaboration in Mental Health Care
6.17 Feb 27, 2018: Hisamitsu Pharmaceutical Announces the Results of Phase III Clinical Study of HP-3000 in Japan
6.18 Feb 27, 2018: The Medicines Company Appoints Dr. Sarah Schlesinger to Its Board of Directors
6.19 Feb 23, 2018: GSK, Ministry of Economy, Trade and Industry 'Superior Health and Good Management Act 2018 (White 500)' for 2 consecutive years certified
6.20 Feb 23, 2018: Sumitomo Dainippon Pharma Names Hiroshi Nomura As President And CEO
6.21 Feb 22, 2018: UCB Full Year Report 2017
6.22 Feb 21, 2018: The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results
6.23 Feb 15, 2018: Camurus: Full year report 2017
6.24 Feb 14, 2018: Sumitomo Dainippon Pharma and Nitto Announce Positive Topline Results from Phase 3 Study Evaluating Transdermal Patch Formulation of Atypical Antipsychotic LONASEN
6.25 Feb 14, 2018: DBV Technologies Provides Update on Regulatory Progress for Viaskin Peanut
6.26 Feb 13, 2018: Naltrexone transdermal patch (Nalsyn) has patent granted in USA
6.27 Feb 08, 2018: Teva Reports 2017 Full Year and Fourth Quarter Financial Results
6.28 Feb 08, 2018: Syneos Health Names Lisa van Capelle Chief Human Resources Officer
6.29 Feb 08, 2018: Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights
6.30 Feb 08, 2018: Syneos Health Names Lisa van Capelle Chief Human Resources Officer
6.31 Feb 07, 2018: Lannett Announces Fiscal 2018 Second-Quarter Financial Results; Reports Record Revenues, Strong Earnings
6.32 Feb 07, 2018: GSK delivers improvements in sales, margins and cash flow in 2017
6.33 Feb 06, 2018: Teva Pharmaceuticals laid off 46 employees in Parsippany
6.34 Feb 05, 2018: EyeGate Announces Top-Line Results for Phase 2b Trial of EGP-437 in Cataract Surgery
6.35 Feb 05, 2018: Allergan Appoints Matthew M. Walsh As Executive Vice President and Chief Financial Officer
6.36 Feb 01, 2018: Japanese Pharmaceutical Company Agrees to 20 Year Settlement Agreement after Attempting to Block Generics
6.37 Feb 01, 2018: Chrono Therapeutics Announces Appointment of David Happel as Chief Executive Officer
6.38 Feb 01, 2018: Lannett Enters Into Consulting Agreement With Former CEO, Arthur Bedrosian
6.39 Jan 31, 2018: Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch
6.40 Jan 31, 2018: Notification of the Results of the Phase III Clinical Study of HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.
6.41 Jan 31, 2018: Lilly Reports Strong Fourth-Quarter and Full-Year 2017 Revenue Growth, Increases 2018 EPS Guidance
6.42 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.43 Jan 27, 2018: Prometheon Pharma Completes Pilot Study of Insulin Patch in Mini-Pigs
6.44 Jan 25, 2018: 3M Reports Fourth-Quarter 2017 Results; Raises 2018 Earnings Outlook
6.45 Jan 24, 2018: Solasia Pharma Announces Head Office Relocation
6.46 Jan 19, 2018: Hisamitsu Pharmaceutical received Japan regulatory approval for ALLESAGA TAPE (HP-3060), a transdermal system for the treatment of allergic rhinitis
6.47 Jan 19, 2018: Teva Layoffs To Affect 65 Employees In Horsham, North Wales
6.48 Jan 18, 2018: Lannett Appoints Timothy C. Crew As Board Of Directors
6.49 Jan 09, 2018: Valeritas Appoints Joseph Saldanha as Chief Business Officer
6.50 Jan 09, 2018: Representative Director and President of GlaxoSmithKline Corporation Personnel notice
6.51 Jan 08, 2018: Allergan Provides 2018 Preliminary Financial Outlook for Select Income Statement Categories and Other Updates at 36th Annual J. P. Morgan Conference
6.52 Jan 04, 2018: EyeGate Promotes Sarah Romano to Chief Financial Officer
6.53 Jan 04, 2018: Generex CEO Provides 2017 Year-End Summary to Stakeholders
6.54 Jan 03, 2018: Zynerba Pharmaceuticals Provides 2018 Clinical and Corporate Update

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Transdermal Drug Delivery - Pipeline Products by Stage of Development
Table 2: Transdermal Drug Delivery - Pipeline Products by Segment
Table 3: Transdermal Drug Delivery - Pipeline Products by Territory
Table 4: Transdermal Drug Delivery - Pipeline Products by Regulatory Path
Table 5: Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
Table 6: Transdermal Drug Delivery - Ongoing Clinical Trials
Table 7: Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development
Table 8: Transdermal Drug Delivery - Pipeline Products by Stage of Development
Table 9: 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Passive Transdermal Clonidine Patch - Product Status
Table 11: Passive Transdermal Clonidine Patch - Product Description
Table 12: Passive Transdermal Fentanyl Patch - Product Status
Table 13: Passive Transdermal Fentanyl Patch - Product Description
Table 14: Passive Transdermal Lidocaine Patch - Product Status
Table 15: Passive Transdermal Lidocaine Patch - Product Description
Table 16: Passive Transdermal Patch - Product Status
Table 17: Passive Transdermal Patch - Product Description
Table 18: Passive Transdermal Scopalamine Patch - Product Status
Table 19: Passive Transdermal Scopalamine Patch - Product Description
Table 20: Transdermal Apomorphine Patch - Product Status
Table 21: Transdermal Apomorphine Patch - Product Description
Table 22: Transdermal Exenatide Patch - Product Status
Table 23: Transdermal Exenatide Patch - Product Description
Table 24: Transdermal FSH Patch - Product Status
Table 25: Transdermal FSH Patch - Product Description
Table 26: Transdermal Patch - Diabetes - Product Status
Table 27: Transdermal Patch - Diabetes - Product Description
Table 28: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 29: GentleDispense System - Product Status
Table 30: GentleDispense System - Product Description
Table 31: Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 32: AQS1301 - Product Status
Table 33: AQS1301 - Product Description
Table 34: AQS1302 - Product Status
Table 35: AQS1302 - Product Description
Table 36: AQS1303 - Product Status
Table 37: AQS1303 - Product Description
Table 38: AQS1304 - Product Status
Table 39: AQS1304 - Product Description
Table 40: Aequus Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 41: AQS1301 - Phase Ia Study of AQS-1301 in Healthy Subjects
Table 42: Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: AG200-ER Patch - Product Status
Table 44: AG200-ER Patch - Product Description
Table 45: AG200-SP Patch - Product Status
Table 46: AG200-SP Patch - Product Description
Table 47: AG890 Patch - Product Status
Table 48: AG890 Patch - Product Description
Table 49: Twirla (AG200-15) - Product Status
Table 50: Twirla (AG200-15) - Product Description
Table 51: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Nanotechnology-Based Transdermal Delivery System - Product Status
Table 53: Nanotechnology-Based Transdermal Delivery System - Product Description
Table 54: Norethindrone Transdermal Delivery System - Product Status
Table 55: Norethindrone Transdermal Delivery System - Product Description
Table 56: Alliqua BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: PHN Patch - Product Status
Table 58: PHN Patch - Product Description
Table 59: Altea Therapeutics Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Transdermal Enoxaparin Sodium Patch - Product Status
Table 61: Transdermal Enoxaparin Sodium Patch - Product Description
Table 62: Transdermal Fentanyl Citrate Patch - Product Status
Table 63: Transdermal Fentanyl Citrate Patch - Product Description
Table 64: Transdermal Protein Patch - Product Status
Table 65: Transdermal Protein Patch - Product Description
Table 66: AMW GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Anastrozole Transdermal Patch - Product Status
Table 68: Anastrozole Transdermal Patch - Product Description
Table 69: Rotigotine Patch - Product Status
Table 70: Rotigotine Patch - Product Description
Table 71: AngioSoma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Transdermal PGE-1 Patch - Product Status
Table 73: Transdermal PGE-1 Patch - Product Description
Table 74: Apogee Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 75: PyraDerm - Product Status
Table 76: PyraDerm - Product Description
Table 77: Apricus Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Second Generation Vitaros Room Temperature Device - Product Status
Table 79: Second Generation Vitaros Room Temperature Device - Product Description
Table 80: Vitaros - Product Status
Table 81: Vitaros - Product Description
Table 82: Asahi Kasei Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Teribone Microneedle Patch System - Product Status
Table 84: Teribone Microneedle Patch System - Product Description
Table 85: AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 86: EMLA Patch - Product Status
Table 87: EMLA Patch - Product Description
Table 88: AstraZeneca Plc - Ongoing Clinical Trials Overview
Table 89: EMLA Patch - Peripheral Intravenous Cannulation in Children with Difficult Vein Access: Randomized Study Comparing Accuvein 400 versus Standard Care
Table 90: Avro Life Sciences Pipeline Products & Ongoing Clinical Trials Overview
Table 91: Transdermal Drug Delivery Patch - Product Status
Table 92: Transdermal Drug Delivery Patch - Product Description
Table 93: Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 94: BLU402 Hydrogel Patch Wart Kit - Product Status
Table 95: BLU402 Hydrogel Patch Wart Kit - Product Description
Table 96: Drug Delivery Patch - Product Status
Table 97: Drug Delivery Patch - Product Description
Table 98: CB Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 99: Pain-Patch - Product Status
Table 100: Pain-Patch - Product Description
Table 101: Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Topical Diclofenac Patch - Product Status
Table 103: Topical Diclofenac Patch - Product Description
Table 104: Chrono Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 105: Biologically-Timed Drug Delivery Device - Product Status
Table 106: Biologically-Timed Drug Delivery Device - Product Description
Table 107: Corium International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 108: Corplex Donepezil Transdermal System - Product Status
Table 109: Corplex Donepezil Transdermal System - Product Description

LIST OF FIGURES

Figure 1: Transdermal Drug Delivery - Pipeline Products by Stage of Development
Figure 2: Transdermal Drug Delivery - Pipeline Products by Segment
Figure 3: Transdermal Drug Delivery - Pipeline Products by Territory
Figure 4: Transdermal Drug Delivery - Pipeline Products by Regulatory Path
Figure 5: Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
Figure 6: Transdermal Drug Delivery - Ongoing Clinical Trials

COMPANIES MENTIONED

4P Therapeutics LLC
Actuated Medical Inc
Aequus Pharmaceuticals Inc
Agile Therapeutics Inc
Allergan Plc
Alliqua BioMedical Inc
Altea Therapeutics Corporation
AMW GmbH
AngioSoma Inc
Apogee Technology Inc
Apricus Biosciences Inc
Asahi Kasei Pharma Corp
AstraZeneca Plc
Avro Life Sciences
Burke Pharmaceuticals LLC
CB Scientific Inc.
Cerimon Pharmaceuticals, Inc.
Chrono Therapeutics Inc
Corium International Inc
DBV Technologies SA
DD Therapeutics LLC
Dermisonics Inc
Dharma Therapeutics, Inc.
Drexel University
DURECT Corp
Echo Therapeutics Inc
Emplicure AB
Endo International Plc
Extend Biosciences Inc
EyeGate Pharmaceuticals Inc
Fe3 Medical Inc
Hisamitsu Pharmaceutical Co Inc
ImmuPatch
Indian Institute of Science
Indian Institute of Technology Bombay
InMed Pharmaceuticals Inc
Institute of Materials Research & Engineering
Intercell AG
Interstitial NS
Isis Biopolymer, Inc.
Janisys
KTH Royal Institute of Technology
Kyowa Hakko Kirin Co Ltd
Lohmann Therapie-Systeme AG
Massachusetts Institute of Technology
Mayne Pharma Group Ltd
Medherant Ltd
MEDRx Co Ltd
MedRx, Inc.
Microdermics Inc
Micron Biomedical Inc
Micropoint Technologies Pte Ltd
Nemaura Pharma Ltd
NeuroDerm Ltd
Nitto Denko Corp
North Carolina State University
Noven Pharmaceuticals Inc
NutriBand Inc
Nuvo Pharmaceuticals Inc
Pain Therapeutics Inc
Phosphagenics Ltd
Prometheon Pharma LLC
Purdue University
Radius Health Inc
Scilex Ltd
Skinject Inc
Sparsha Pharma International Pvt Ltd
Sparsha Pharma USA Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stanford University
Sumitomo Dainippon Pharma Co Ltd
Syntropharma Ltd
Taho Pharmaceuticals Ltd
Teikoku Pharma USA Inc
tesa Labtec GmbH
Teva Pharmaceutical Industries Ltd
The Sheikh Zayed Institute for Pediatric Surgical Innovation
TheraJect Inc
TheraSolve NV
Theratech, Inc.
Titan Pharmaceuticals Inc
Transcu Group Limited
Transdermal Delivery Solutions Corp
Transdermal Specialties, Inc.
TransPharma Medical Ltd
Transport Pharmaceuticals Inc
TSRL Inc
Univec, Inc.
University of Illinois at Chicago
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill School of Medicine
University of Toronto
ViiV Healthcare UK Ltd
Vyteris, Inc.
Xel Pharmaceuticals Inc
Zambon Italia Srl
Z-Cube Srl
Zosano Pharma Corp
Zynerba Pharmaceuticals Inc


More Publications